Why monkey studies may mislead research on cancer immunotherapy drugs targeting TIGIT

A new study published in the Journal of Biological Chemistry from UC Davis Comprehensive Cancer Center finds that TIGIT, an immune checkpoint receptor targeted by cancer immunotherapy drugs, triggers a different response in rhesus macaques…

Continue Reading

News Source: medicalxpress.com